RETATRUTIDE
10mg
CJC-1295 NO DAC
10mg
CJC-1295 No DAC
GHRH Analogue Research Peptide
10mg
$60.00
Available
- Straightforward ordering with confirmed catalog details.
- For laboratory research use only.
Product Overview
CJC-1295 No DAC, also described as Modified GRF(1-29), is a GHRH analogue studied in growth hormone-releasing hormone receptor and GH-axis signaling research.
It is distinct from long-acting, DAC-containing CJC-1295. Research interest includes GHRH-receptor signaling, peptide stability, and structure–activity questions around the Modified GRF(1-29) sequence.
Research Interests
- GHRH analogue research
- GHRH receptor / GH-axis signaling
- Peptide stability research
- Structure–activity research
Want to read more?
View ResearchCertificates of Analysis
Laboratory reports for the dosages documented on this product. Only results printed on each certificate are shown.
Certificates of Analysis and product records will appear here as they are published.